U.s orthopedic biomaterials market - Reports Corner

on

  • 268 views

In 2012, the U.S. market for orthopedic biomaterials was valued at almost $3.4 billion. This total comprises eight different market segments. ...

In 2012, the U.S. market for orthopedic biomaterials was valued at almost $3.4 billion. This total comprises eight different market segments.
The orthopedic biomaterials market has undergone a shift away from certain devices and towards new areas and medical devices. There is still tremendous potential for growth, especially in the younger market segments such as stem cells and concentration systems.

https://www.reportscorner.com/reports/26973/U.S-Orthopedic-Biomaterials-Market/

Statistics

Views

Total Views
268
Views on SlideShare
268
Embed Views
0

Actions

Likes
0
Downloads
0
Comments
0

0 Embeds 0

No embeds

Accessibility

Upload Details

Uploaded via as Microsoft PowerPoint

Usage Rights

© All Rights Reserved

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Processing…
Post Comment
Edit your comment

U.s orthopedic biomaterials market - Reports Corner U.s orthopedic biomaterials market - Reports Corner Presentation Transcript

  • RC Reports Corner U.S Orthopedic Biomaterials Market
  • DescriptionDescription Reports Cornerwww.reportscorner.com In 2012, the U.S. market for orthopedic biomaterials was valued at almost $3.4 billion. This total comprises eight different market segments. The orthopedic biomaterials market has undergone a shift away from certain devices and towards new areas and medical devices. There is still tremendous potential for growth, especially in the younger market segments such as stem cells and concentration systems.
  • Brief SummaryBrief Summary Reports Cornerwww.reportscorner.com In 2012, the U.S. market for orthopedic biomaterials was valued at almost $3.4 billion. This total comprises eight different market segments. The orthopedic biomaterials market has undergone a shift away from certain devices and towards new areas and medical devices. There is still tremendous potential for growth, especially in the younger market segments such as stem cells and concentration systems. Conversely, some products that previously experienced rapid market growth have now entered maturity, but even these markets are sustained by continued product evolution. Scope: This report pertains to a forecast period of 10 years (2009 – 2019) for the U.S. Report Contents: Competitor Analysis Identified Strategic Opportunities Market Overview by Segment & Country
  • Brief SummaryBrief Summary Reports Cornerwww.reportscorner.com Trend Analysis by Segment & Country Market Drivers & Limiters Mergers & Acquisitions Customer Feedback and Market Monitoring Main Segments Included: Orthopedic Bone Graft Substitute Orthopedic Growth Factor Orthopedic Stem Cell Orthopedic Cell Therapy Orthopedic Hyaluronic Acid Viscosupplementation Orthopedic Tendon Graft Orthopedic Cartilage Repair Spinal Machined Bone Allograft Sub-Segments Included: Autograft Standard Allograft
  • Brief SummaryBrief Summary Reports Cornerwww.reportscorner.com Demineralized Bone Matrix Synthetic Bone Graft Xenograft BMP-2 BMP-7 Human Embryonic Stem Cells Mesengchymal Stem Cells Lumbar Spine Stem Cells Cervical Spine Stem Cells Platelet-Rich Plasma Orthopedic Concentrated Bone Marrow Aspirate Single-Injection Three-Injection Cycle Three/Five-Injection Cycle BTB Graft
  • Brief SummaryBrief Summary Reports Cornerwww.reportscorner.com Soft Tissue Grafts Ligament and Tendon Synthetic Graft Osteochondral Allograft Autologous Chondrocyte Implantation Meniscal Allograft Tansplantation ALIF Machined Bone Allograft PLIF Machined Bone Allograft TLIF Machined Bone Allograft CIF Machined Bone Allograft Companies Included: Sanofi-Aventis/Genzyme Bioventus DePuy Synthes Medtronic Musculoskeletal Transplant Foundation
  • Brief SummaryBrief Summary Reports Cornerwww.reportscorner.com Stryker RTI Biologics NuVasive Orthofix LifeNet Health AlloSource Integra LifeSciences Anika Therapeutics Biomet Ferring Pharmaceuticals Exactech Baxter Harvest Technologies Cytomedix Wright Medical
  • Brief SummaryBrief Summary Reports Cornerwww.reportscorner.com Community Tissue Services Olympus Biotech Fidia Arteriocyte Alphatec Spine Joint Restoration Foundation University of Miami Tissue Bank Celling Biosciences Zimmer Reasons To Buy: This report analyzes and evaluates the current state of the market including existing and potential markets, product average selling prices, and unit volumes. The report also highlights the opportunities and potential hazards involved, and presents strategies for successfully navigating the market landscape.
  • Brief SummaryBrief Summary Reports Cornerwww.reportscorner.com Furthermore, it seeks to identify the trends and technologies that will affect the future of each market segment and prepares an unbiased critical assessment of such market drivers and limiters based on our “ground up” approach, which includes primary and secondary research methods.
  • Table of ContentsTable of Contents Reports Cornerwww.reportscorner.com TABLE OF CONTENTS ............................................................................................................................ I LIST OF FIGURES ................................................................................................................................. IX LIST OF CHARTS .................................................................................................................................. XV EXECUTIVE SUMMARY ......................................................................................................................... 1 1.1 ORTHOPEDIC BIOMATERIALS MARKET OVERVIEW ................................................................................ 1 1.2 ORTHOPEDIC BONE GRAFT SUBSTITUTE MARKET .................................................................................. 2 1.3 ORTHOPEDIC GROWTH FACTOR MARKET ............................................................................................... 3 1.4 ORTHOPEDIC STEM CELL MARKET ......................................................................................................... 4 1.5 ORTHOPEDIC CELL THERAPY MARKET ................................................................................................... 5 1.6 ORTHOPEDIC HYALURONIC ACID VISCOSUPPLEMENTATION MARKET .................................................. 6 1.7 ORTHOPEDIC TENDON GRAFT MARKET .................................................................................................. 7 1.8 ORTHOPEDIC CARTILAGE REPAIR MARKET ............................................................................................ 8 1.9 COMPETITIVE ANALYSIS ......................................................................................................................... 9 RESEARCH METHODOLOGY ............................................................................................................. 11 2.1 RESEARCH SCOPE .................................................................................................................................. 11 2.2 IDATA’S 9-STEP METHODOLOGY .......................................................................................................... 11 Step 1: Project Initiation & Team Selection ................................................................................................ 12 Step 2: Prepare Data Systems and Perform Secondary Research .............................................................. 13 Step 3: Preparation for Interviews & Questionnaire Design ...................................................................... 14 Step 4: Performing Primary Research ........................................................................................................ 14 Step 5: Research Analysis: Establishing Baseline Estimates ...................................................................... 16 Step 6: Market Forecast and Analysis......................................................................................................... 17 Step 7: Identify Strategic Opportunities ...................................................................................................... 19 Step 8: Final Review and Market Release ................................................................................................... 20 Step 9: Customer Feedback and Market Monitoring .................................................................................. 20
  • Table of ContentsTable of Contents Reports Cornerwww.reportscorner.com ORTHOPEDIC BIOMATERIALS MARKET OVERVIEW ............................................................... 21 3.1 INTRODUCTION ...................................................................................................................................... 21 3.1.1 Bone Graft Substitutes ........................................................................................................................ 22 3.1.2 Growth Factors .................................................................................................................................. 22 3.1.3 Orthopedic Stem Cell Therapy ........................................................................................................... 23 3.1.4 Cell Therapies .................................................................................................................................... 23 3.1.5 Hyaluronic Acid Viscosupplementation ............................................................................................. 24 3.1.6 Tendon Grafts ..................................................................................................................................... 24 3.1.7 Cartilage Repair ................................................................................................................................. 24 3.2 MARKET OVERVIEW .............................................................................................................................. 25 3.3 TREND ANALYSIS .................................................................................................................................. 30 3.4 MARKET DRIVERS AND LIMITERS ......................................................................................................... 33 3.4.1 Market Drivers ................................................................................................................................... 33 3.4.2 Market Limiters .................................................................................................................................. 33 3.5 COMPETITIVE ANALYSIS ....................................................................................................................... 36 3.5.1 Leading Competitors .......................................................................................................................... 36 3.6 MARKET CONCENTRATION .................................................................................................................... 42 3.7 MERGERS AND ACQUISITIONS ............................................................................................................... 44 ORTHOPEDIC BONE GRAFT SUBSTITUTE MARKET ................................................................. 49 4.1 INTRODUCTION ...................................................................................................................................... 49 4.2 MARKET SEGMENTATION ...................................................................................................................... 50 4.2.1 By Indication ...................................................................................................................................... 50 4.2.1.1 Spine ................................................................................................................................................ 50 4.2.1.2 Thoracolumbar Spine ...................................................................................................................... 50 4.2.1.3 Cervical Spine ................................................................................................................................. 50 4.2.1.4 Trauma ............................................................................................................................................ 51 4.2.1.5 Extremities ....................................................................................................................................... 51
  • Table of ContentsTable of Contents Reports Cornerwww.reportscorner.com 4.2.2 By Material ......................................................................................................................................... 51 4.2.2.1 Autograft .......................................................................................................................................... 51 4.2.2.2 Standard Allograft ........................................................................................................................... 51 4.2.2.3 Demineralized Bone Matrix ............................................................................................................ 51 4.2.2.4 Synthetic .......................................................................................................................................... 52 4.2.2.5 Xenograft ......................................................................................................................................... 52 4.3 PROCEDURES ......................................................................................................................................... 53 4.3.1 Bone Graft Substitute Procedures ...................................................................................................... 53 4.4 UNITS PER PROCEDURE ......................................................................................................................... 54 4.5 MARKET OVERVIEW .............................................................................................................................. 56 4.5.1 Bone Graft Substitute Market by Material ......................................................................................... 58 4.5.2 Bone Graft Substitute Market by Indication ....................................................................................... 61 4.6 MARKET ANALYSIS & FORECAST ......................................................................................................... 64 4.6.1 Bone Graft Substitute Market by Material ......................................................................................... 64 4.6.1.1 Total Allograft Bone Graft Substitute Market ................................................................................. 64 4.6.1.2 Total Demineralized Bone Matrix (DBM) Bone Graft Substitute Market ....................................... 79 4.6.1.3 Total Synthetic Bone Graft Substitute Market ................................................................................. 96 4.6.2 Bone Graft Substitute Market by Indication ..................................................................................... 111 4.6.2.1 Spine Bone Graft Substitute Market .............................................................................................. 111 4.6.2.2 Cervical Spine Bone Graft Substitute Market ............................................................................... 113 4.6.2.3 Thoracolumbar Spine Bone Graft Substitute Market .................................................................... 115 4.6.2.4 Trauma Bone Graft Substitute Market .......................................................................................... 117 4.6.2.5 Non-union Trauma Fracture Bone Graft Substitute Market ......................................................... 119 4.6.2.6 Fresh Fracture Trauma Bone Graft Substitute Market ................................................................. 120 4.6.2.7 Large Joint Reconstruction Bone Graft Substitute Market ........................................................... 121 4.6.2.8 Hip Large Joint Reconstruction Bone Graft Substitute Market .................................................... 123 4.6.2.9 Knee Large Joint Reconstruction Bone Graft Substitute Market .................................................. 124
  • Table of ContentsTable of Contents Reports Cornerwww.reportscorner.com 4.6.2.10 Foot Reconstruction Bone Graft Substitute Market .................................................................... 125 4.6.2.11 Craniomaxillofacial Bone Graft Substitute Market..................................................................... 127 4.6.2.12 Oncology Bone Graft Substitute Market ..................................................................................... 129 4.7 MARKET DRIVERS AND LIMITERS ....................................................................................................... 131 4.7.1 Market Drivers ................................................................................................................................. 131 4.7.1.1 Allograft Bone Graft Substitute Market ........................................................................................ 131 4.7.1.2 Demineralized Bone Matrix (DBM) Bone Graft Substitute Market .............................................. 131 4.7.1.3 Synthetic Bone Graft Substitute Market ........................................................................................ 132 4.7.2 Market Limiters ................................................................................................................................ 134 4.7.2.1 Allograft Bone Graft Substitute Market ........................................................................................ 134 4.7.2.2 Demineralized Bone Matrix (DBM) Bone Graft Substitute Market .............................................. 134 4.7.2.3 Synthetic Bone Graft Substitute Market ........................................................................................ 135 4.8 COMPETITIVE ANALYSIS ..................................................................................................................... 136 4.8.1 Allograft Bone Graft Substitute Market ........................................................................................... 136 4.8.2 Demineralized Bone Matrix (DBM) Bone Graft Substitute Market ................................................. 140 4.8.3 Synthetic Bone Graft Substitute Market ........................................................................................... 143 4.8.4 Total Bone Graft Substitute Market ................................................................................................. 147 ORTHOPEDIC GROWTH FACTOR MARKET ............................................................................... 149 5.1 INTRODUCTION .................................................................................................................................... 149 5.2 MARKET OVERVIEW ............................................................................................................................ 149 5.2.1 BMP-2 (Medtronic) .......................................................................................................................... 150 5.2.2 BMP-7 (Olympus Biomaterials) ....................................................................................................... 150 5.2.3 Reimbursement ................................................................................................................................. 151 5.2.4 Future Indications ............................................................................................................................ 151 5.3 MARKET ANALYSIS & FORECAST ....................................................................................................... 152 5.4 MARKET DRIVERS AND LIMITERS ....................................................................................................... 154 5.4.1 Market Drivers ................................................................................................................................. 154
  • Table of ContentsTable of Contents Reports Cornerwww.reportscorner.com 5.4.2 Market Limiters ................................................................................................................................ 154 5.5 COMPETITIVE ANALYSIS ..................................................................................................................... 157 ORTHOPEDIC STEM CELL MARKET............................................................................................. 159 6.1 INTRODUCTION .................................................................................................................................... 159 6.2 MARKET OVERVIEW ............................................................................................................................ 159 6.2.1 Lineage ............................................................................................................................................. 159 6.2.1.1 Human Embryonic Stem Cells (hESC) .......................................................................................... 159 6.2.1.2 Mesenchymal Stem Cells (MSC) ................................................................................................... 160 6.2.2 Legislation ........................................................................................................................................ 160 6.2.3 Other Therapeutic Applications ....................................................................................................... 160 6.3 MARKET ANALYSIS & FORECAST ....................................................................................................... 161 6.3.1.1 Lumbar Spine Stem Cell Market ................................................................................................... 165 6.3.1.2 Cervical Spine Stem Cell Market .................................................................................................. 167 6.4 DRIVERS AND LIMITERS ...................................................................................................................... 169 6.4.1 Market Drivers ................................................................................................................................. 169 6.4.2 Market Limiters ................................................................................................................................ 169 6.5 COMPETITIVE ANALYSIS ..................................................................................................................... 171 ORTHOPEDIC CELL THERAPY MARKET .................................................................................... 175 7.1 INTRODUCTION .................................................................................................................................... 175 7.1.1 Platelet-Rich Plasma ........................................................................................................................ 176 7.1.2 Concentrated Bone Marrow Aspirate .............................................................................................. 177 7.2 MARKET OVERVIEW ............................................................................................................................ 178 7.3 MARKET ANALYSIS & FORECAST ....................................................................................................... 182 7.3.1 Platelet-Rich Plasma Market ........................................................................................................... 182 7.3.1.1 Spinal Platelet-Rich Plasma Market ............................................................................................. 187 7.3.1.2 Soft Tissue Reconstruction Platelet-Rich Plasma Market ............................................................. 188
  • Table of ContentsTable of Contents Reports Cornerwww.reportscorner.com 7.3.1.3 Joint Reconstruction Platelet-Rich Plasma Market ...................................................................... 189 7.3.1.4 Cardiac Surgery Platelet-Rich Plasma Market ............................................................................. 190 7.3.1.5 Other Platelet-Rich Plasma Markets ............................................................................................. 191 7.3.2 Orthopedic Concentrated Bone Marrow Aspirate Market ............................................................... 192 7.3.2.1 Spine Concentrated Bone Marrow Aspirate Market ..................................................................... 197 7.3.2.2 Trauma Concentrated Bone Marrow Aspirate Market ................................................................. 198 7.3.2.3 Joint Reconstruction Concentrated Bone Marrow Aspirate Market ............................................. 199 7.3.2.4 Other Concentrated Bone Marrow Aspirate Market ..................................................................... 200 7.4 MARKET DRIVERS AND LIMITERS ....................................................................................................... 201 7.4.1 Market Drivers ................................................................................................................................. 201 7.4.2 Market Limiters ................................................................................................................................ 202 7.5 COMPETITIVE ANALYSIS ..................................................................................................................... 204 ORTHOPEDIC HYALURONIC ACID VISCOSUPPLEMENTATION MARKET ....................... 207 8.1 INTRODUCTION .................................................................................................................................... 207 8.1.1 Benefits of Viscosupplementation ..................................................................................................... 208 8.1.2 Synovial Fluid .................................................................................................................................. 208 8.1.3 Product Types ................................................................................................................................... 209 8.1.3.1 Single-Injection Products .............................................................................................................. 209 8.1.3.2 Three-Injection Cycle Products ..................................................................................................... 209 8.1.3.3 Three/Five-Injection Cycle Products ............................................................................................ 209 8.1.4 Reimbursement ................................................................................................................................. 209 8.2 MARKET OVERVIEW ............................................................................................................................ 210 8.3 MARKET ANALYSIS & FORECAST ....................................................................................................... 214 8.3.1 Single-Injection Hyaluronic Acid Viscosupplementation Market .................................................... 214 8.3.2 Three-Injection Hyaluronic Acid Viscosupplementation Market ..................................................... 216 8.3.3 Five-Injection Hyaluronic Acid Viscosupplementation Market ....................................................... 218 8.4 MARKET DRIVERS AND LIMITERS ....................................................................................................... 220
  • Table of ContentsTable of Contents Reports Cornerwww.reportscorner.com 8.4.1 Market Drivers ................................................................................................................................. 220 8.4.2 Market Limiters ................................................................................................................................ 221 8.5 COMPETITIVE ANALYSIS ..................................................................................................................... 223 ORTHOPEDIC TENDON GRAFT MARKET .................................................................................... 227 9.1 INTRODUCTION .................................................................................................................................... 227 9.2 MARKET OVERVIEW ............................................................................................................................ 228 9.2.1 BTB ................................................................................................................................................... 228 9.2.2 Soft Tissue Grafts ............................................................................................................................. 228 9.2.3 Allografted Tendons ......................................................................................................................... 228 9.2.4 Ligament and Tendon Synthetic Grafts ............................................................................................ 229 9.3 MARKET ANALYSIS & FORECAST ....................................................................................................... 230 9.3.1 ACL/PCL Reconstruction Procedures .............................................................................................. 230 9.3.2 ACL/PCL Allograft Tendon Market ................................................................................................. 232 9.4 DRIVERS AND LIMITERS ...................................................................................................................... 234 9.4.1 Market Drivers ................................................................................................................................. 234 9.4.2 Market Limiters ................................................................................................................................ 235 9.5 COMPETITIVE ANALYSIS ..................................................................................................................... 236 ORTHOPEDIC CARTILAGE REPAIR MARKET ........................................................................... 239 10.1 INTRODUCTION .................................................................................................................................. 239 10.1.1 Anatomy .......................................................................................................................................... 239 10.1.2 Methods for Cartilage Repair ........................................................................................................ 240 10.1.2.1 Osteochondral Allograft Transfer ............................................................................................... 240 10.1.2.2 Autologous Chondrocyte Implantation (ACI) ............................................................................. 240 10.1.2.3 Meniscal Allograft Transplantation ............................................................................................ 240 10.2 MARKET OVERVIEW .......................................................................................................................... 241 10.3 MARKET ANALYSIS AND FORECAST ................................................................................................. 245
  • Table of ContentsTable of Contents Reports Cornerwww.reportscorner.com 10.3.1 Osteochondral Cartilage Allograft Market .................................................................................... 246 10.3.2 Meniscal Allograft Market ............................................................................................................. 247 10.3.3 Autologous Chondrocyte Implantation Market .............................................................................. 248 10.4 MARKET DRIVERS AND LIMITERS ..................................................................................................... 249 10.4.1 Market Drivers ............................................................................................................................... 249 10.4.2 Market Limiters .............................................................................................................................. 249 10.5 COMPETITIVE ANALYSIS ................................................................................................................... 251 SPINAL MACHINED BONE ALLOGRAFT MARKET ................................................................... 255 11.1 INTRODUCTION .................................................................................................................................. 255 11.1.1 Machined Bone ............................................................................................................................... 257 11.2 MARKET OVERVIEW .......................................................................................................................... 258 11.3 MARKET ANALYSIS & FORECAST ..................................................................................................... 261 11.3.1 Spinal Machined Bone Allograft Market by Segment .................................................................... 261 11.3.1.1 ALIF Machined Bone Allograft Market ...................................................................................... 262 11.3.1.2 PLIF Machined Bone Allograft Market ...................................................................................... 263 11.3.1.3 TLIF Machined Bone Allograft Market ....................................................................................... 264 11.3.1.4 CIF Machined Bone Allograft Market ........................................................................................ 265 11.4 MARKET DRIVERS AND LIMITERS ..................................................................................................... 266 11.4.1 Market Drivers ............................................................................................................................... 266 11.4.2 Market Limiters .............................................................................................................................. 267 11.5 COMPETITIVE ANALYSIS ................................................................................................................... 270 ABBREVIATIONS ................................................................................................................................. 273
  • For more informationFor more information Reports Cornerwww.reportscorner.com For more information please visit our website https://www.reportscorner.com/reports/26973/U.S-Orthopedic-Biomaterials-Market/
  • Reports Corner Thank YouThank You www.reportscorner.com RC Contact us: contact@reportscorner.com